Evaluation of water-soluble metallofullerenes as MRI contrast agents.
Drug Discovery Institute, Nihon Schering K.K., Osaka, Japan.
Masafumi
M
Okumura
Masahito
M
Mikawa
Takashi
T
Yokawa
Yoko
Y
Kanazawa
Haruhito
H
Kato
Hisanori
H
Shinohara
D000818:Animals; D002244:Carbon / Q000737:chemistry / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid; D003287:Contrast Media / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics; D005260:Female; D037741:Fullerenes; D005682:Gadolinium / Q000737:chemistry / Q000493:pharmacokinetics; D019786:Gadolinium DTPA; D008279:Magnetic Resonance Imaging; D051379:Mice; D019906:Nuclear Magnetic Resonance, Biomolecular; D011522:Protons; D012995:Solubility; D014018:Tissue Distribution
D003287:Contrast Media; D037741:Fullerenes; D011522:Protons; C108127:fullerenol; D002244:Carbon; D005682:Gadolinium; D019786:Gadolinium DTPA